- Home
- PRTA vs RPAY Comparison
PRTA vs RPAY Comparison
Compare PRTA & RPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- RPAY
- Stock Information
- Founded
- PRTA 2012
- RPAY 2006
- Country
- PRTA Ireland
- RPAY United States
- Employees
- PRTA N/A
- RPAY N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- RPAY Business Services
- Sector
- PRTA Health Care
- RPAY Consumer Discretionary
- Exchange
- PRTA Nasdaq
- RPAY Nasdaq
- Market Cap
- PRTA 472.1M
- RPAY 473.8M
- IPO Year
- PRTA N/A
- RPAY N/A
- Fundamental
- Price
- PRTA $8.16
- RPAY $5.66
- Analyst Decision
- PRTA Buy
- RPAY Buy
- Analyst Count
- PRTA 10
- RPAY 9
- Target Price
- PRTA $12.29
- RPAY $7.22
- AVG Volume (30 Days)
- PRTA 935.9K
- RPAY 709.3K
- Earning Date
- PRTA 11-11-2025
- RPAY 11-11-2025
- Dividend Yield
- PRTA N/A
- RPAY N/A
- EPS Growth
- PRTA N/A
- RPAY N/A
- EPS
- PRTA N/A
- RPAY N/A
- Revenue
- PRTA $10,341,000.00
- RPAY $310,367,000.00
- Revenue This Year
- PRTA N/A
- RPAY N/A
- Revenue Next Year
- PRTA $389.77
- RPAY $9.47
- P/E Ratio
- PRTA N/A
- RPAY N/A
- Revenue Growth
- PRTA N/A
- RPAY 1.45
- 52 Week Low
- PRTA $4.32
- RPAY $3.59
- 52 Week High
- PRTA $22.71
- RPAY $9.75
- Technical
- Relative Strength Index (RSI)
- PRTA 51.80
- RPAY 50.70
- Support Level
- PRTA $8.19
- RPAY $5.62
- Resistance Level
- PRTA $8.50
- RPAY $5.96
- Average True Range (ATR)
- PRTA 0.33
- RPAY 0.21
- MACD
- PRTA -0.09
- RPAY -0.03
- Stochastic Oscillator
- PRTA 16.18
- RPAY 26.17
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About RPAY Repay Holdings Corporation
Repay Holdings Corp is engaged in providing integrated payment processing solutions to verticals that have transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments.